Market Movers: Emcure, Tata Steel, RBL Bank Among Today’s Top Picks

Nifty Poised for Upside as Pharma, Banking and Infrastructure Names Take Centre Stage

Domestic equities eye secular momentum ahead of June series roll over

India’s benchmark indices are set to open with positive bias as pharmas Emcure and Aurobindo lead sector rotation, while banking and infrastructure heavyweights RBL Bank and Power Grid capture investor attention. Market watchers anticipate pickup in midcap action after a consolidation phase.

Market Overview

Domestic markets have displayed resilience over the past two sessions, with the Nifty 50 hovering around the 20,200 mark and the Sensex maintaining a firm grip above 69,000. The advance decline ratio continues to favour bulls, supported by healthy flows into equities. The roll over in the June derivatives series is scheduled for 18 May and participants are positioning well in selected sectoral themes. Volatility is expected to remain elevated, but spot liquidity in quality names is attracting fresh buyers.

Stock Specific Analysis

Emcure Pharma has been in focus after Q4 numbers beat consensus estimates, reporting 18.2 percent year on year growth in revenue and stable margin performance. The stock recently broke above its 200 day moving average, drawing technical buying. Aurobindo Pharma, another heavyweight in the space, is benefiting from easing supply chain constraints in the US formulation business and better pricing environment. With institutional investors adding to their positions, upside momentum may persist.

HFCL is capturing attention after securing an order pipeline worth Rs 1,250 crore for optical fiber and telecom transmission equipment. The order win is expected to add visibility to the upcoming quarters. RBL Bank, despite near term provisioning concerns, is witnessing healthy deposit accretion and improving asset quality metrics. The comeback trajectory in net interest margins and fee income segments has investors optimistic.

Sectoral Performance

Coal India continues to trade at steep discount to its replacement value, even as volume offtake recovers post summer demand peak. Tata Steel is adjusting to the global supply glut, but its domestic portfolio and captive iron ore advantages provide a cushion. In hospitality, ITC Hotels is poised for sharp rebound as occupancy and average room rates climb back after festival season demand. On the power transmission front, Power Grid is benefiting from tariff hikes approved by the regulator and stable capex guidance.

Godfrey Phillips is back in spotlight on the back of robust export performance and diversification into nascent markets. Lower currency headwinds and steady domestic volumes lend support to the cigarette major’s earnings profile. Investors are watching its margin trajectory and working capital cycles as key triggers.

Strategy Implications and Outlook

With global cues mixed and US Fed policy on hold, domestic flows are expected to gravitate towards quality cyclical and defensive names. Selective exposure to midcaps with strong order books or improving asset reconstruction stories can pay off. Option traders are skewing call writing around 20,500 strikes on Nifty, indicating measured optimism. Short term traders may consider tactical long positions in pharma counters and infrastructure plays, while value investors can reallocate across beaten down metal and coal stocks for dividend yield capture.

  • Emcure Pharma continues to outperform after better than expected Q4 earnings and technical breakout above 200 DMA
  • Aurobindo Pharma trading higher on easing supply constraints and pricing tailwinds in US formulations
  • HFCL secures fresh orders worth Rs 1,250 crore boosting near term revenue visibility
  • RBL Bank shows signs of recovery in margin expansion and stable asset quality
  • Power Grid gains from regulatory tariff hikes and steady capex allocation

Investor Note: Maintain a balanced portfolio stance as momentum names in pharma and infrastructure drive near term gains. Focus on high conviction long positions in midcap semi cyclical stocks with visible earnings runway while hedging broader market exposure to manage volatility risks effectively.

Spread the Word

Leave a Reply

Your email address will not be published. Required fields are marked *